搜索临床试验以:VLY-686
总计1159个结果
-
International Institute of Rescue Research and...未知
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)完全的
-
Andalas UniversityNational Institute of Health Research and Development, Ministry of Health Republic of Indonesia完全的
-
Ihsan GURSEL, PhD, Prof.The Scientific and Technological Research Council of Turkey; MonitorCRO; Nobel Pharmaceuticals完全的
-
Volastra Therapeutics, Inc.招聘中胃腺癌 | 子宫癌肉瘤 | 三阴性乳腺癌 | 晚期实体瘤 | 头颈部鳞状细胞癌 | 食管腺癌 | 食管鳞状细胞癌 | 膀胱移行细胞癌 | 结直肠腺癌 | 胃食管结合部腺癌 | 子宫浆液性癌 | 卵巢癌肉瘤 | 卵巢高级别浆液性腺癌 | 子宫内膜癌 | 鳞状非小细胞肺癌 | 染色体不稳定美国
-
Relay Therapeutics, Inc.主动,不招人胆管癌 | 肝内胆管癌 | FGFR2基因突变 | FGFR2 扩增 | FGFR2 基因融合/重排 | FGFR2基因易位 | FGFR2 基因激活 | 其他实体瘤,成人美国, 法国, 意大利, 英国, 大韩民国, 西班牙, 台湾, 瑞典, 德国, 荷兰, 新加坡, 澳大利亚, 香港
-
NCIC Clinical Trials GroupCascadian Therapeutics Inc.完全的
-
Kezar Life Sciences, Inc.撤销
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的
-
Metro International Biotech, LLCChildren's Hospital of Philadelphia完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pfizer终止慢性期慢性粒细胞白血病,BCR-ABL1 阳性 | Blasts Under 15 Percent of Bone Marrow Nucleated Cells | Blasts Under 15 Percent of Peripheral Blood White Cells | Blasts Under 30 Percent of Bone Marrow Nucleated Cells | Blasts Under 30 Percent of Peripheral Blood White Cells美国